负压吸疱法检测白癜风皮损揭示疾病活动性生物标志物
本研究通过改良负压吸疱技术微创采集白癜风患者和健康人的皮肤间质液,检测细胞因子和T细胞浸润。在筛选和验证组中,活动性皮损的CD8+ T细胞数量和CXCL9蛋白浓度显著高于非皮损区,CXCL9的ROC分析显示更高灵敏度和特异度。结论认为直接测量皮肤CXCL9可能作为临床试验中治疗反应的早期标志物。
要点
- 活动性白癜风皮损中CD8+ T细胞数量和CXCL9蛋白浓度显著升高。
- CXCL9蛋白浓度在ROC分析中表现出更高的灵敏度和特异度。
- 负压吸疱法可微创评估皮肤炎症,支持流式细胞术和蛋白定量。
核心结论
- 直接测量皮肤CXCL9可能作为临床试验中治疗反应的早期标志物。
- 改良负压吸疱技术支持使用流式细胞术和蛋白定量研究炎症性皮肤病。
研究设计与样本
- 通过改良负压吸疱技术采集白癜风患者和健康人的皮肤间质液。
- 潜在生物标志物先在筛选组定义,后在独立验证组验证。
主要发现
- 在筛选和验证中,活动性皮损的CD8+ T细胞数量和CXCL9蛋白浓度显著高于非皮损皮肤。
- CXCL9蛋白浓度通过ROC分析达到更高的灵敏度和特异度。
- 负压吸疱法可对T细胞浸润进行表型分析,浸润T细胞绝大多数表达CXCR3。
关键数值与推荐
- 活动性皮损相比非皮损皮肤:CD8+ T细胞数量和CXCL9蛋白浓度显著升高。
- CXCL9蛋白浓度在ROC分析中灵敏度和特异度更高。
- 浸润T细胞绝大多数表达C-X-C趋化因子受体3(CXCR3)。
临床怎么用
- 负压吸疱法可用于微创、客观地评估白癜风皮肤细胞因子和T细胞浸润。
- 皮肤CXCL9测量可能作为临床试验中治疗反应的早期标志物。
局限性
- 研究入组患者数量少。
- 仅使用一名患者定义治疗反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vitiligo is an autoimmune disease of the skin with limited treatment options; there is an urgent need to identify and validate biomarkers of disease activity to support vitiligo clinical studies. OBJECTIVE: To investigate potential biomarkers of disease activity directly in the skin of vitiligo subjects and healthy subjects. METHODS: Patient skin was sampled via a modified suction-blister technique, allowing for minimally invasive, objective assessment of cytokines and T-cell infiltrates in the interstitial skin fluid. Potential biomarkers were first defined and later validated in separate study groups. RESULTS: In screening and validation, CD8+ T-cell number and C-X-C motif chemokine ligand (CXCL) 9 protein concentration were significantly elevated in active lesional compared to nonlesional skin. CXCL9 protein concentration achieved greater sensitivity and specificity by receiver operating characteristic analysis. Suction blistering also allowed for phenotyping of the T-cell infiltrate, which overwhelmingly expresses C-X-C motif chemokine receptor 3. LIMITATIONS: A small number of patients were enrolled for the study, and only a single patient was used to define the treatment response. CONCLUSION: Measuring CXCL9 directly in the skin might be effective in clinical trials as an early marker of treatment response. Additionally, use of the modified suction-blister technique supports investigation of inflammatory skin diseases using powerful tools like flow cytometry and protein quantification.
引用
- Strassner JP, Rashighi M, Ahmed Refat M, et al. Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity. J Am Acad Dermatol. 2017. PMID: 28259440. doi:10.1016/j.jaad.2016.12.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。